Telomerase inhibitors for the treatment of cancer: the current perspective (Q34481887)

2 August 2017

1 reference

title

Telomerase inhibitors for the treatment of cancer: the current perspective (English)

1 reference

2 August 2017

Perry PJ

1

1 reference

2 August 2017

Arnold JR

series ordinal

2

1 reference

2 August 2017

Jenkins TC

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

10

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

2141-2156

1 reference

Telomerase inhibitors: targeting the vulnerable end of cancer?

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Telomerase: a therapeutic target for the third millennium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

21 January 2018

Telomerase and cancer

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Switching and signaling at the telomere

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

DNA tetraplex-binding drugs: structure-selective targeting is critical for antitumour telomerase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Secondary structure of vertebrate telomerase RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

The telomerase RNA pseudoknot is critical for the stable assembly of a catalytically active ribonucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Human telomerase RNA-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

A stem-loop of Tetrahymena telomerase RNA distant from the template potentiates RNA folding and telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Human telomerase contains two cooperating telomerase RNA molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Cellular delivery of peptide nucleic acids and inhibition of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Inhibition of human telomerase by 7-deaza-2'-deoxyguanosine nucleoside triphosphate analogs: potent inhibition by 6-thio-7-deaza-2'-deoxyguanosine 5'-triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

G-quadruplex DNA structures--variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Structures of the potassium-saturated, 2:1, and intermediate, 1:1, forms of a quadruplex DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

6-Thioguanine alters the structure and stability of duplex DNA and inhibits quadruplex DNA formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Structural dynamics and cation interactions of DNA quadruplex molecules containing mixed guanine/cytosine quartets revealed by large-scale MD simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

G-Quadruplex DNA as a target for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

G-quadruplexes as targets for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

G-quadruplex DNA: a potential target for anti-cancer drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Induction of duplex to G-quadruplex transition in the c-myc promoter region by a small molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

DNA tetraplex formation in the control region of c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Design and synthesis of the G-quadruplex-specific cleaving reagent perylene-EDTA.iron(II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

A DNA-porphyrin minor-groove complex at atomic resolution: The structural consequences of porphyrin ruffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Structural characterization of a guanine-quadruplex ligand complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Telomerase: biology and phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2141

10.1517/13543784.10.12.2141

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference